Regulatory regimes such as the EU FMD and U.S. DSCSA drive serialization to strengthen visibility and oversight, but these ...
Matt Sample breaks down the operational hurdles and strategies for transitioning to the FDA’s new 12-digit NDC format. While ...
From KPI clarity to right-sized staffing, Kimberly Howard explains how to measure true FRM impact and build flexible models ...
In today's Pharma Pulse, the FDA grants expanded approval for Imcivree, while new research highlights how optimizing pharmacy ...
As global temperatures continue to rise and weather patterns grow more volatile, the pharmaceutical industry faces a mounting ...
Jordan Armstrong outlines how adaptable DTP programs can reduce barriers and accelerate patient access to therapy. As ...
Pharmaceutical manufacturers have historically relied on intermediaries—including pharmacy benefit managers (PBMs), ...
Jordan Armstrong outlines how adaptable DTP programs can reduce barriers and accelerate patient access to therapy. Jordan Armstrong, VP of Business Development at AssistRX, explains how companies can ...
In today's Pharma Pulse, the FDA grants a 54-day fast-track approval for high-dose Wegovy under a new priority program while ...
PharmaKonnect and co-founder of Tina’s Warriors, discusses the biggest post therapy launch patient support gaps.
As manufacturers and stakeholders work to streamline patient access at therapy launch, a critical gap often persists in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results